These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29960113)

  • 1. The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides.
    Malliou F; Andreadou I; Gonzalez FJ; Lazou A; Xepapadaki E; Vallianou I; Lambrinidis G; Mikros E; Marselos M; Skaltsounis AL; Konstandi M
    J Nutr Biochem; 2018 Sep; 59():17-28. PubMed ID: 29960113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARα.
    Zhou W; Du Z
    J Sci Food Agric; 2024 Nov; 104(14):8634-8645. PubMed ID: 38952322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleuropein-Induced Acceleration of Cytochrome P450-Catalyzed Drug Metabolism: Central Role for Nuclear Receptor Peroxisome Proliferator-Activated Receptor α.
    Malliou F; Andriopoulou CE; Gonzalez FJ; Kofinas A; Skaltsounis AL; Konstandi M
    Drug Metab Dispos; 2021 Sep; 49(9):833-843. PubMed ID: 34162688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoceptor-related decrease in serum triglycerides is independent of PPARα activation.
    Konstandi M; Kypreos KE; Matsubara T; Xepapadaki E; Shah YM; Krausz K; Andriopoulou CE; Kofinas A; Gonzalez FJ
    FEBS J; 2019 Nov; 286(21):4328-4341. PubMed ID: 31230416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
    Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
    McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linalool is a PPARα ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome.
    Jun HJ; Lee JH; Kim J; Jia Y; Kim KH; Hwang KY; Yun EJ; Do KR; Lee SJ
    J Lipid Res; 2014 Jun; 55(6):1098-110. PubMed ID: 24752549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Study on Beneficial Effects of Hydroxytyrosol- and Oleuropein-Rich Olive Leaf Extracts on High-Fat Diet-Induced Lipid Metabolism Disturbance and Liver Injury in Rats.
    Fki I; Sayadi S; Mahmoudi A; Daoued I; Marrekchi R; Ghorbel H
    Biomed Res Int; 2020; 2020():1315202. PubMed ID: 31998777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
    Goto T; Kim YI; Funakoshi K; Teraminami A; Uemura T; Hirai S; Lee JY; Makishima M; Nakata R; Inoue H; Senju H; Matsunaga M; Horio F; Takahashi N; Kawada T
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1022-32. PubMed ID: 21862726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
    Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
    J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleuropein Promotes Neural Plasticity and Neuroprotection via PPARα-Dependent and Independent Pathways.
    Malliou F; Andriopoulou CE; Kofinas A; Katsogridaki A; Leondaritis G; Gonzalez FJ; Michaelidis TM; Darsinou M; Skaltsounis LA; Konstandi M
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
    Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
    Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-oxo-10(E),12(E)-Octadecadienoic acid derived from tomato is a potent PPAR α agonist to decrease triglyceride accumulation in mouse primary hepatocytes.
    Kim YI; Hirai S; Takahashi H; Goto T; Ohyane C; Tsugane T; Konishi C; Fujii T; Inai S; Iijima Y; Aoki K; Shibata D; Takahashi N; Kawada T
    Mol Nutr Food Res; 2011 Apr; 55(4):585-93. PubMed ID: 21462326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs.
    Kasai S; Inoue T; Yoshitomi H; Hihara T; Matsuura F; Harada H; Shinoda M; Tanaka I
    J Pharmacol Sci; 2008 Sep; 108(1):40-8. PubMed ID: 18776709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist.
    Mukherjee R; Locke KT; Miao B; Meyers D; Monshizadegan H; Zhang R; Search D; Grimm D; Flynn M; O'Malley KM; Zhang L; Li J; Shi Y; Kennedy LJ; Blanar M; Cheng PT; Tino J; Srivastava RA
    J Pharmacol Exp Ther; 2008 Dec; 327(3):716-26. PubMed ID: 18799592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PPARα and HNF4α in stress-mediated alterations in lipid homeostasis.
    Konstandi M; Shah YM; Matsubara T; Gonzalez FJ
    PLoS One; 2013; 8(8):e70675. PubMed ID: 23967086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.